PHARM NL0010391025

Real Time Euronext Amsterdam - 25/10 17:35:04
0.7934	EUR		-1.07%

22/10	BEURSAGENDA : Nederlandse bedrijven	AM
22/10	BEURSAGENDA : Nederlandse bedrijven	AM
21/10	BEURSAGENDA : Nederlandse bedrijven	AM

Nieuws

Persberichten

Officiële publicaties

Sectornieuws

Analyse MarketScreener

Communiqués de presse de la société PHARMING GROUP N.V.

22/10	PHARMING N : Pharming Group Notice of 9M Results	PU
22/10	PHARMING N : Group Notice of 9M Results	PU
14/09	PHARMING N : Pharming announces results from clinical trials for the treatment of COVID-19..	PU
14/09	PHARMING N : announces results from clinical trials for the treatment of COVID-19 with RUC..	PU
14/09	PHARMING N : publiceert resultaten van klinische studies naar de behandeling van COVID-19 ..	PU
05/08	PHARMING N : Group reports financial results for the first half of 2021	PU
29/07	SIGN UP NOW : Pharming's Half Year Financial Results Webinar	PU
20/07	PHARMING N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..	PU
01/07	PHARMING N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..	PU
01/07	ORCHARD THERAPEUTICS : and Pharming Group Announce Collaboration to Develop and Commercial..	AQ
23/06	PHARMING N : Pharming announces completion of enrolment in Phase II/III study with lenioli..	PU
23/06	PHARMING N : announces completion of enrolment in Phase II/III study with leniolisib for a..	PU
18/06	PHARMING N : Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as..	PU
18/06	PHARMING N : benoemt Anurag Relan tot Chief Medical Officer en Robert Friesen tot Chief Sc..	PU
18/06	PHARMING N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..	PU
04/06	PHARMING N : announces the reimbursement of RUCONEST® in Spain	PU
01/06	PHARMING N : Group to present at Jefferies Virtual Healthcare Conference	PU
13/05	PHARMING N : Group reports financial results for the first quarter of 2021	PU
17/03	PHARMING N : Group presenteert tijdens de 31ste jaarlijkse Oppenheimer Healthcare Conferen..	PU
11/03	PHARMING N : Group presenteert op BioCapital Europe 2021	PU
08/03	PHARMING N : Phishing, Pharming, Malware, And Other Internet Delights	AQ
02/03	PHARMING N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..	PU
02/03	PHARMING N : Group start, in samenwerking met Invitae Corporation, genetisch testprogramma..	PU
2020	PHARMING N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..	PU
2020	PHARMING N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..	PU
2020	PHARMING N : Reports on Extraordinary General Meeting of Shareholders	PU
2020	PHARMING N : announces enrolment of first patient in US clinical trial for the treatment o..	PU
2020	PHARMING N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..	PU
2020	PHARMING N : announces commitment to build a new downstream manufacturing facility for RUC..	PU
2020	PHARMING N : appoints Jeroen Wakkerman as Chief Financial Officer	PU
2020	PHARMING N : Group reports financial results for the first nine months of 2020	PU
2020	PHARMING N : convenes Extraordinary General Meeting of shareholders	PU
2020	PHARMING N : receives Orphan Drug Designation from the European Commission for leniolisib ..	PU
2020	PHARMING N : announces the publication of data from a compassionate use programme of RUCON..	PU
2020	PHARMING N : announces enrolment of first patient in multinational clinical trial for the ..	PU
2020	PHARMING N : Group reports financial results for the first half of 2020	PU
2020	PHARMING N : Seven Ways to Rob You during COVID-19	AQ
2020	PHARMING N : reports encouraging results from use of RUCONEST® in COVID-19 patients	PU
2020	PHARMING N : Group convenes Annual General Meeting of shareholders	PU
2020	PHARMING N : Publication of Pharming's 2019 Annual Report	PU
2020	PHARMING N : CFO to step down	PU
2020	PHARMING N : Group Reports Strong Preliminary (Unaudited) Financial Results for 2019	PU
2020	PHARMING N : receives EMA approval of new facility for expansion of RUCONEST® production	PU
2020	PHARMING N : announces the placement of €125 million senior unsecured convertible bonds du..	PU
2020	PHARMING N : announces the launch of an offering of approximately €125 million senior unse..	PU
2019	PHARMING : responds to press speculation	PU
2019	PHARMING : announces completion of minority investment in BioConnection BV Pharming announ..	PU
2019	PHARMING : Press releaseMarch 28 Pharming Group announces publication of its Annual Report..	PU
2018	PHARMING : reports favourable conclusion from first investigator-initiated direct comparat..	PU
2018	PHARMING : reports interim financial results for the first nine months of 2018	PU
2018	PHARMING : reports positive data from first investigator-initiated study of rhC1-Inhibitor..	PU
2018	PHARMING : Receives Complete Response Letter from FDA	PU
2018	PHARMING : announces further issue of shares as employee options are exercised	PU
2018	PHARMING : Capital Market Briefing recording and slide deck	PU
2018	PHARMING : Sign up for Pharming's Capital Markets Briefing – Webinar details inside	PU
2018	PHARMING : announces Agenda for its Capital Markets Briefing to be held on 21 June 2018 in..	PU
2018	PHARMING : Interim Report on Financial Results for the First Quarter 2018	PU
2018	A GLOBAL AWARENESS DAY FOR A RARE LI : World HAEday, 16th May 2018	PU
2018	PHARMING : announces publication of 2017 Annual Report and invitation to Annual General Me..	PU
2017	PHARMING : Submits Supplemental Biologics License Application to FDA for RUCONEST® for Pro..	PU
2017	PHARMING : announces positive data from paediatric clinical trial with RUCONEST®	PU
2017	PHARMING : N.V. and HAEi International Patient Organization announce partnership with Ince..	PU
2017	PHARMING : announces cashless warrant exercises and conversions of its Ordinary Bonds into..	PU
2017	PHARMING : Reports on Financial Results for the First Half of 2017	PU
2017	PHARMING : announces publication of RUCONEST® prophylactic data in The Lancet	PU
2017	PHARMING : announces completion of its refinancing with a single US$100 million debt facil..	PU
2017	PHARMING : announces withdrawal of agenda items related to Amendment of the Articles of As..	PU
2017	PHARMING : Interim Report on Financial Results for the First Quarter 2017	PU
2017	PHARMING : announces refinancing of its existing debt by a single US$100 million debt faci..	PU
2017	A GLOBAL AWARENESS DAY FOR A RARE LI : World HAEday, 16th May 2017	PU
2017	PHARMING : Report on Preliminary Financial Results for 2016	PU
2017	VAN LEEUWENHOECK ISSUES RESEARCH NOT : Turning the Page	PU
2017	PHARMING : announces additional conversions of its Amortizing Bonds	PU
2017	PHARMING : announces issue of new stock as a result of conversion of Amortizing Bonds	PU
2017	PHARMING : announces issue of new stock as a result of conversion of Amortizing Bonds	PU